AI Day1 LLC - May 26, 2021 Form 3 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
10%+ Owner
Signature
/s/ Alejandro Moreno for AI Day 1 LLC
Stock symbol
DAWN
Transactions as of
May 26, 2021
Transactions value $
$0
Form type
3
Date filed
5/26/2021, 08:34 PM
Next filing
Jun 3, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DAWN Series A Redeemable Convertible Preferred Stock May 26, 2021 Common Stock 7.76M Direct F1, F2
holding DAWN Series B Redeemable Convertible Preferred Stock May 26, 2021 Common Stock 741K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each outstanding share of Series A Redeemable Convertible Preferred Stock will each automatically convert into one share of common stock of Day One Biopharmaceuticals, Inc. (the "Issuer") immediately prior to the completion of the Issuer's initial public offering and has no expiration date.
F2 The securities reported are held directly by AI Day 1 LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI Day 1 LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
F3 Each outstanding share of Series B Redeemable Convertible Preferred Stock will each automatically convert into one share of common stock of the Issuer immediately prior to the completion of the Issuer's initial public offering and has no expiration date.

Remarks:

Exhibit List: Ex.24 - Power of Attorney